
Similar trends were seen in study participants that transitioned from receiving placebo to bimekizumab after study week 16.
Victoria Johnson joined the MJH Life Sciences in 2020 and has written for NeurologyLive, CGTLive, and now HCPLive. You can reach her at [email protected]

Similar trends were seen in study participants that transitioned from receiving placebo to bimekizumab after study week 16.

Adjusted analyses reveal a statistically significantly higher prescription medication cost in patients with RA compared to those without.